Trial Profile
Mechanism of action study of Ustekinumab treatment in psoriatic arthritis: Impact on cellular and molecular pathways of synovial inflammation and tissue remodeling
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2015
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms MoA-Ustekinumab
- 20 Feb 2015 New trial record